Literature DB >> 15855634

Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis.

Brigham C Willis1, Janice M Liebler, Katherine Luby-Phelps, Andrew G Nicholson, Edward D Crandall, Roland M du Bois, Zea Borok.   

Abstract

The hallmark of idiopathic pulmonary fibrosis (IPF) is the myofibroblast, the cellular origin of which in the lung is unknown. We hypothesized that alveolar epithelial cells (AECs) may serve as a source of myofibroblasts through epithelial-mesenchymal transition (EMT). Effects of chronic exposure to transforming growth factor (TGF)-beta1 on the phenotype of isolated rat AECs in primary culture and a rat type II cell line (RLE-6TN) were evaluated. Additionally, tissue samples from patients with IPF were evaluated for cells co-expressing epithelial (thyroid transcription factor (TTF)-1 and pro-surfactant protein-B (pro-SP-B), and mesenchymal (alpha-smooth muscle actin (alpha-SMA)) markers. RLE-6TN cells exposed to TGF-beta1 for 6 days demonstrated increased expression of mesenchymal cell markers and a fibroblast-like morphology, an effect augmented by tumor necrosis factor-alpha (TNF-alpha). Exposure of rat AECs to TGF-beta1 (100 pmol/L) resulted in increased expression of alpha-SMA, type I collagen, vimentin, and desmin, with concurrent transition to a fibroblast-like morphology and decreased expression of TTF-1, aquaporin-5 (AQP5), zonula occludens-1 (ZO-1), and cytokeratins. Cells co-expressing epithelial markers and alpha-SMA were abundant in lung tissue from IPF patients. These results suggest that AECs undergo EMT when chronically exposed to TGF-beta1, raising the possibility that epithelial cells may serve as a novel source of myofibroblasts in IPF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15855634      PMCID: PMC1606388          DOI: 10.1016/s0002-9440(10)62351-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  59 in total

Review 1.  Idiopathic pulmonary fibrosis: new insights in its pathogenesis.

Authors:  Annie Pardo; Moisés Selman
Journal:  Int J Biochem Cell Biol       Date:  2002-12       Impact factor: 5.085

2.  The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression.

Authors:  A Cano; M A Pérez-Moreno; I Rodrigo; A Locascio; M J Blanco; M G del Barrio; F Portillo; M A Nieto
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

3.  Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro.

Authors:  J M Fan; Y Y Ng; P A Hill; D J Nikolic-Paterson; W Mu; R C Atkins; H Y Lan
Journal:  Kidney Int       Date:  1999-10       Impact factor: 10.612

4.  Transforming growth factor-beta and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes.

Authors:  Mats Grände; Asa Franzen; Jan-Olof Karlsson; Lars E Ericson; Nils-Erik Heldin; Mikael Nilsson
Journal:  J Cell Sci       Date:  2002-11-15       Impact factor: 5.285

5.  Evidence that fibroblasts derive from epithelium during tissue fibrosis.

Authors:  Masayuki Iwano; David Plieth; Theodore M Danoff; Chengsen Xue; Hirokazu Okada; Eric G Neilson
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

6.  Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.

Authors:  Changgong Li; Nian-Ling Zhu; Rosemarie C Tan; Philip L Ballard; Rik Derynck; Parviz Minoo
Journal:  J Biol Chem       Date:  2002-08-02       Impact factor: 5.157

7.  Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis.

Authors:  Y Miyazaki; K Araki; C Vesin; I Garcia; Y Kapanci; J A Whitsett; P F Piguet; P Vassalli
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 8.  Re-evaluation of fibrogenic cytokines in lung fibrosis.

Authors:  Margaret Kelly; Martin Kolb; Phillipe Bonniaud; Jack Gauldie
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

9.  Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group.

Authors:  Ronald G Crystal; Peter B Bitterman; Brooke Mossman; Marvin I Schwarz; Dean Sheppard; Laura Almasy; Harold A Chapman; Scott L Friedman; Talmadge E King; Leslie A Leinwand; Lance Liotta; George R Martin; David A Schwartz; Gregory S Schultz; Carston R Wagner; Robert A Musson
Journal:  Am J Respir Crit Care Med       Date:  2002-07-15       Impact factor: 21.405

10.  Mechanisms and kinetics of Bowman's epithelial-myofibroblast transdifferentiation in the formation of glomerular crescents.

Authors:  Yoshihide Fujigaki; Di Fei Sun; Taiki Fujimoto; Takayuki Suzuki; Tetsuo Goto; Katsuhiko Yonemura; Tetsuo Morioka; Eishin Yaoita; Akira Hishida
Journal:  Nephron       Date:  2002-09       Impact factor: 2.847

View more
  394 in total

1.  Very low levels of vitamin D in systemic sclerosis patients.

Authors:  Paola Caramaschi; Alessandra Dalla Gassa; Orazio Ruzzenente; Alessandro Volpe; Viviana Ravagnani; Ilaria Tinazzi; Giovanni Barausse; Lisa M Bambara; Domenico Biasi
Journal:  Clin Rheumatol       Date:  2010-05-09       Impact factor: 2.980

2.  miR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis.

Authors:  Shanzhong Yang; Na Xie; Huachun Cui; Sami Banerjee; Edward Abraham; Victor J Thannickal; Gang Liu
Journal:  FASEB J       Date:  2012-06-01       Impact factor: 5.191

3.  Role of epithelial-mesenchymal transition in repair of the lacrimal gland after experimentally induced injury.

Authors:  Samantha You; Orna Avidan; Ayesha Tariq; Ivy Ahluwalia; Paul C Stark; Claire L Kublin; Driss Zoukhri
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-17       Impact factor: 4.799

4.  Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment.

Authors:  Amir F Kagalwalla; Noorain Akhtar; Samantha A Woodruff; Bryan A Rea; Joanne C Masterson; Vincent Mukkada; Kalyan R Parashette; Jian Du; Sophie Fillon; Cheryl A Protheroe; James J Lee; Katie Amsden; Hector Melin-Aldana; Kelley E Capocelli; Glenn T Furuta; Steven J Ackerman
Journal:  J Allergy Clin Immunol       Date:  2012-04-01       Impact factor: 10.793

Review 5.  Idiopathic pulmonary fibrosis-an epidemiological and pathological review.

Authors:  Andrea T Borchers; Christopher Chang; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

6.  Guiding epithelial cell phenotypes with engineered integrin-specific recombinant fibronectin fragments.

Authors:  Ashley C Brown; Jessica A Rowe; Thomas H Barker
Journal:  Tissue Eng Part A       Date:  2010-12-12       Impact factor: 3.845

Review 7.  Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions.

Authors:  Nathan J Godde; Ryan C Galea; Imogen A Elsum; Patrick O Humbert
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-12       Impact factor: 2.673

8.  Evidence for epithelial-mesenchymal transition in adult human pancreatic exocrine cells.

Authors:  Marjorie Fanjul; Valéry Gmyr; Coralie Sengenès; Ginette Ratovo; Marlène Dufresne; Bruno Lefebvre; Julie Kerr-Conte; Etienne Hollande
Journal:  J Histochem Cytochem       Date:  2010-06-07       Impact factor: 2.479

Review 9.  Eosinophils in innate immunity: an evolving story.

Authors:  Revital Shamri; Jason J Xenakis; Lisa A Spencer
Journal:  Cell Tissue Res       Date:  2010-11-03       Impact factor: 5.249

10.  MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation.

Authors:  Chaoqun Huang; Xiao Xiao; Ye Yang; Amorite Mishra; Yurong Liang; Xiangming Zeng; Xiaoyun Yang; Dao Xu; Michael R Blackburn; Craig A Henke; Lin Liu
Journal:  J Biol Chem       Date:  2017-07-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.